British Heart Foundation Response To New Cholesterol Drug - Evacetrapib

Editor's Choice
Academic Journal
Main Category: Cholesterol
Article Date: 15 Nov 2011 - 5:00 PST

email to a friend   printer friendly   opinions  

High LDL, or bad cholesterol levels increase the risk of developing cardiovascular diseases, especially in those with high LDL levels and low levels of HDL (good cholesterol).

At the American Heart Association's Scientific Sessions 2011 researchers presented preliminary findings on the efficacy of evacetrapib on cholesterol levels in 398 patients with high LDL levels and low HDL levels, which indicate it may substantially increase levels of good cholesterol whilst lowering bad cholesterol levels.

Senior Cardiac Nurse, Natasha Stewart from the British Heart Foundation commented on the study:

"This study indicates that evacetrapib may potentially have some effect on helping to lower bad cholesterol and improve good cholesterol levels in the blood. However, it is a very small study performed over a very short period of time, and we need to see studies on a larger scale to determine how beneficial this drug will be in the long run. We already know statins can be beneficial in reducing the level of cholesterol in your blood, and help to protect healthy but high-risk people from heart disease, as well preventing repeated problems in people who have already had a heart attack, a stroke or been diagnosed with peripheral artery disease.

We also know that making simple changes in your lifestyle such as having a diet that is low in fat, and participating in regular physical activity, can also help lower your cholesterol and keep your heart healthy."

Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our cholesterol section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Petra Rattue. "British Heart Foundation Response To New Cholesterol Drug - Evacetrapib." Medical News Today. MediLexicon, Intl., 15 Nov. 2011. Web.
15 Nov. 2011. APA

Please note: If no author information is provided, the source is cited instead.

Rate this article:
(Hover over the stars then click to rate)

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here